A randomized, double-blind, parallel group, placebo-controlled study to investigate the efficacy, safety, and tolerability of ML-004 in adolescents and adults with autism spectrum disorders (ASD).
ML-004 in ASD
What is the goal of the study?
Study objectives are to evaluate the safety and tolerability of ML-004 compared with placebo in subjects with ASD, and to evaluate efficacy of ML-004 compared with placebo in the improvement of social communication deficits in patients with ASD.
Who can participate in the study?
Please contact the study team listed below to learn more.